FDA rejection

big wave over ship in storm
Favicon Fierce Biotech

Disc lays off 20% of workforce in wake of FDA rejection

Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate.
James Waldron Mar 3, 2026 10:45am
Union Square in San Francisco during JPM 2026
Favicon Fierce Biotech

JPM26: Sanofi looks ahead to lingering US policy hurdles

Jan 14, 2026 2:28pm
U-turn pivot about-face

Atara, Pierre Fabre receive 2nd US rejection for Ebvallo

Jan 12, 2026 11:30am
jet lag sleep disorder

FDA rejects Vanda's Hetlioz for a 2nd time in jet lag disorder

Jan 8, 2026 11:20am
An envelope with rejected mark Vector illustration
Favicon Fierce Biotech

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Jan 6, 2026 4:30am
Regeneron

FDA rejects Eylea HD for ongoing manufacturing issues

Oct 28, 2025 11:52am